Abstract

Here, we report the establishment of the human iPS cell line N1-FiPS4F#7 generated from skin cells of a patient with no rheumatic diseases, thus obtaining an appropriate control iPS cell line for researchers working in the field of rheumatic diseases. The reprogramming factors Oct4, Sox2, Klf4 and c-Myc were introduced using a non-integrating reprogramming strategy involving Sendai Virus.

Highlights

  • Genetic Modification Type of Modification Associated disease Gene/locus Method of modification Name of transgene or resistance Inducible/constitutive system Date archived/stock date

  • Resource utility iPSC-lines have been generated from patients with rheumatic diseases, there is still lack of appropriate control lines generated from patients with radiographic information regarding principal joints

  • Dermal fibroblasts were isolated from a skin biopsy of a donor with nor radiographic signs neither symptoms of rheumatic diseases using a protocol previously described (Vangipuram et al, 2013)

Read more

Summary

Resource utility

IPSC-lines have been generated from patients with rheumatic diseases, there is still lack of appropriate control lines generated from patients with radiographic information regarding principal joints (knee, hip, hands and/or spine). We generated a control iPS cell line from a donor with no rheumatic diseases, as proved radiographically

Resource details
Result
Isolation and characterization of dermal fibroblasts
Non-integrative reprogramming of fibroblasts
RNA extraction and qRT-PCR analyses
EB formation and in vitro differentiation
Immunofluorescence analyses
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.